Clinical Trials Directory

Trials / Conditions / Autoimmune Thrombocytopenia

Autoimmune Thrombocytopenia

8 registered clinical trials studyying Autoimmune Thrombocytopenia — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingInaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune
NCT06826430
Juventas Cell Therapy Ltd.Phase 1
Not Yet RecruitingIASO-782 in Autoimmune Hematological Diseases
NCT06534021
Shanghai IASO Biotechnology Co., LtdPhase 1
RecruitingConception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflamma
NCT04902807
Institut National de la Santé Et de la Recherche Médicale, France—
CompletedDietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus
NCT03421184
University Hospital, BordeauxN/A
CompletedEltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disord
NCT01610180
Fondazione Progetto EmatologiaPhase 2
CompletedThe Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia
NCT01667263
Peking University People's HospitalPhase 2
CompletedInitial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.
NCT04070599
University Hospital, BordeauxPhase 3
UnknownThe ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
NCT01101295
Henri Mondor University Hospital—